Skip to main content
Menu

Cosmetic Medicine - Monthly Reports

List of monthly reports on Cosmetic Medicine

Cosmetic Research Analysis

March’s cosmetic research was dominated by translational biomaterials and function-first reconstruction, led by a phase II randomized intra-patient controlled trial showing a tissue-engineered autologous dermo-epidermal graft (denovoSkin) improves scar quality. A prospective functional abdominal wall reanimation for Prune Belly Syndrome shifted reconstructive aims from contour to measurable physiology. Regenerative scaffolds (silk-fibroin/GelMA) accelerated healing, reduced scarring, and even in

Cosmetic Research Analysis

February’s cosmetic research combined high-quality randomized and systematic evidence with translational technology. A multicenter RCT established PLLA as a durable, safe option for temporal augmentation, while a systematic review supported partial breast irradiation (with technique-specific caveats) to preserve oncologic safety and cosmetic outcomes. Mechanistic advances identified CD68 as a regulator of melanocyte development, expanding targets for depigmenting strategies, and a time-resolved

Cosmetic Research Analysis

January’s cosmetic research was defined by translational biomaterials, disease-responsive dermal delivery, and procedure-level innovations that preserve function and aesthetics. Top signals include a druggable collagen–integrin pathway linking environmental nanoplastics to neurodegeneration, an intranasal BBB-bypass nanolamellar system enabling sequential mitochondria-targeted therapy, and a CRISPR-enabled platform for scalable human type III collagen with in vivo wound-healing efficacy. Dermal

Cosmetic Research Analysis

December’s cosmetic research converged on mechanism-driven rejuvenation, objective outcome measurement, and translatable delivery platforms. High-impact mechanistic studies highlighted NRP1-mediated vascular normalization to prevent scarring and POR-mediated ferroptosis as an anti-photoaging target, while recombinant COL17 advanced epidermal repair. Practice-facing evidence included a randomized trial supporting hydroquinone-sparing TXA/niacinamide regimens for melasma and device optimization wi

Cosmetic Research Analysis

November’s cosmetic research spotlighted safer, practice‑ready therapies and upstream platforms that will shape product pipelines. Randomized evidence supports tranexamic acid + niacinamide creams as hydroquinone‑sparing options for melasma, while a TRPM8 agonist cream reduced chronic prurigo activity and improved barrier function. A meta‑analysis confirmed onabotulinumtoxinA as an effective, durable non‑surgical option for platysmal neck bands. Translational biology identified plasma 5‑methoxyt

Cosmetic Research Analysis

October’s cosmetic research delivered practice-changing clinical trials and critical safety signals. A randomized semi-endoscopic trans-axillary breast augmentation reduced deformities and capsular contracture, while a registered RCT showed toluidine-blue photodynamic therapy can nonchemically preserve oral aesthetics during orthodontics with plaque control comparable to chlorhexidine/fluoride. A multimodal microneedle platform combined antibiotics and phototherapy to eradicate MRSA in vivo, hig

Cosmetic Research Analysis

September’s cosmetic research centered on safety surveillance, standardized testing, and procedural risk reduction. A non-targeted analytics pipeline (FBMN + QSIIR + in silico toxicity) advanced detection of concealed cosmetic adulterants. ISO 23675 validated an in vitro Double Plate SPF method that can reduce human testing burden while improving label confidence. A PRISMA meta-analysis quantified facial artery course, diameter, and depth via Doppler ultrasound, translating directly into safer f

Cosmetic Research Analysis

August’s cosmetic-focused research coalesced around noninvasive dermatologic oncology, injectable aesthetics, and perioperative biomaterials. A phase III randomized trial established red-light ALA-PDT as an effective, cosmetically favorable treatment for superficial basal cell carcinoma, while a network meta-analysis clarified trade-offs in Bowen’s disease between long-term clearance and scar quality. Translational biomaterials advanced with an injectable zwitterionic hydrogel that eliminated po

Cosmetic Research Analysis

July’s cosmetic research blended mechanistic safety insights with practice-shaping clinical evidence. A sex-aware gonads/epidermis-on-a-chip platform emerged as a transformative tool to model endocrine–epidermal crosstalk, while a mechanistic study flagged zinc oxide nanoparticles for peroxisomal lipid disruption via the SIRT1–FOXO3–ACBD5 axis. Randomized trials supported durable, high-quality outcomes from injectables, including PLLA for midface volume and a new monophasic HA filler non-inferio

Cosmetic Research Analysis

June’s cosmetic-focused literature connected safety-by-design science, precision procedural choices, and outcome-driven planning. A mechanistic study in ACS Nano showed dissolved ions, not intact nanoparticles, drive most toxicity, informing safer nano-enabled cosmetic formulations alongside regulatory advances in reconstructed-epidermis phototoxicity assays. Clinical practice was shaped by noninvasive oncologic care (single-session rhenium-SCT with excellent cosmesis), patient-reported outcome–

Cosmetic Research Analysis

May’s cosmetic research emphasized procedure safety, formulation-driven improvements in skin quality, and biomaterial-associated immune modulation. High-level syntheses support technique selection, with IMRT reducing chronic hyperpigmentation after breast radiotherapy. A randomized split-face trial showed glycerol-enhanced hyaluronic acid improved pore volume and hydration with good tolerability. Translational data linked breast implants to local and systemic immune activation, suggesting potent

Cosmetic Research Analysis

Across April, cosmetic research converged on practice-changing clinical trials, mechanism-driven safety science, and deployable diagnostics. A Lancet phase-3 head-to-head RCT showed topical delgocitinib outperformed oral alitretinoin for severe chronic hand eczema with fewer adverse events, while a randomized, evaluator-blinded trial validated the durability and safety of a new cross-linked hyaluronic acid filler for chin augmentation. Methodologically, a Y-shaped DNA electrochemical sensor enab

Cosmetic Research Analysis

March 2025 cosmetic research converged on scalable ingredient creation, earlier and more precise diagnostics, and device-enabled therapies. A Nature Communications platform expanded the isoprenoid chemical space for fragrances and bioactive topicals, while an RCT mapped rapid microbiome and biomarker shifts that precede visible dandruff flares, enabling earlier endpoints. Point-of-care autologous skin cell suspension (ASCS) with laser delivered rapid, meaningful repigmentation in stable vitiligo

Cosmetic Research Analysis

February’s cosmetic research was led by high-quality randomized and real-world evidence and by platform innovations. A Phase 3 pediatric RCT of once-daily roflumilast 0.05% expanded steroid-sparing options for toddlers with atopic dermatitis, while a triple-blind trial favored biomimetic hydroxyapatite–fluoride toothpastes for pediatric enamel caries. Harmonized international breast implant registries delivered robust, clinically actionable revision risk estimates. On the technology front, a fle

Cosmetic Research Analysis

January’s cosmetic-related research converged on exposure science, precision imaging, regenerative integration, and translational nanomedicine. Human exposure experiments showed that personal care products can amplify dermal uptake and predicted serum levels of environmental SVOCs, reshaping risk assessment and formulation strategy. Non-invasive multispectral optoacoustic tomography achieved histology-correlated tumor mapping for pigmented BCC, supporting more tissue-sparing surgery. Mechanistic